Imaging Contrast

Contrast agents are injected into patients to help enhance images to make it easier for radiologists distinguish specific areas of the body from surrounding tissues. The most commonly used agents are iodinated contrast dye for computed tomography (CT), interventional cath lab angiography,  RF fluoroscopy, and in surgical OR procedures. MRI scans typically use gadolinium-based contrast agents. Ultrasound and echocardiography (cardiac ultrasound) imaging use contrast agents composed of microscopic bubbles to enhance images that otherwise would be suboptimal.

RSS icon
Thumbnail

GBCA doses can be reduced by over 50% for some MRI exams

In some cases, contrast doses can be reduced by as much as 62% without sacrificing diagnostic quality.

ACR updates requirements for on-site staff overseeing contrast administration

A clinician trained to manage reactions should be on-site at any imaging facilities doing contrast studies to maintain patient safety.

AI is still one of the key technologies on the floor many radiologists want to learn more about. of the AI. A product rep discussing breast automated detection AI in the crowded Lunit booth at RSNA 2022.

9 technology trends and takeaways from RSNA 2022

Here are some interesting new technologies and key trends from the vast expo floor at the Radiological Society of North America 2022 meeting.

New contrast agent receives FDA approval after competitors collaborate on development

The Sept. 21 announcement states that Gadopiclenol Injection—a highly stable macrocyclic gadolinium-based contrast agent—is approved for use in adult and pediatric patients aged 2 years and older during MRI exams.

Arl Van Moore, MD, American College of Radiology (ACR) delegate to the American Medical Association (AMA) House of Delegates, former ACR president, chairman of the ACR Board and former CEO of Strategic Radiology, discusses two radiology related policy decisions at the AMA 2022 meeting. These included a AMA policy on the iodine contrast shortage and AUC CDS. #AMA #AMA22 #AMAmtg #AMA175 #ACR

VIDEO: Radiology takeaways from the 2022 AMA meeting

Arl Van Moore, MD, American College of Radiology (ACR) delegate to the American Medical Association House of Delegates, former ACR president, chairman of the ACR Board and former CEO of Strategic Radiology, discusses radiology-related policy decisions at the AMA 2022 meeting.

An example of spectral cardiac CT being used to show iodine density in the myocardium to show perfusion deficits. Shown by Philips healthcare at ACC 2022.

VIDEO: Mitigating the contrast media shortage impact on CT imaging

Brian Ghoshhajra, MD, MBA, division chief, cardiovascular imaging, Massachusetts General Hospital and associate professor of radiology, Harvard Medical School, explains the impact of the iodine contrast shortage on computed tomography (CT) and cardiac imaging.
 

Contrast shortage update: GE expects supply to 'progressively recover' soon

Production at the facility in Shanghai is expected to be near 100% starting on June 6.

Iodine contrast being loaded into a contrast injector in preparation for a cardiac CT scan at Duly Health and Care in Lisle, Illinois. The contrast shortage is causing some healthcare organizations to postpone exams and procedures and ration contrast supplies. Photo by Dave Fornell

ACR working with FDA and HHS to help address imaging contrast shortage

The American College of Radiology (ACR) announced this week its government relations staff has been engaging federal agencies in an effort to improve product availability and hasten resolution of the ongoing iodine contrast shortage.

Displaying 1 - 8 of 18

Around the web

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

Cardiovascular Business
GE HealthCare moves PET/CT scanner production to United States

The all-in-one Omni Legend PET/CT scanner is now being manufactured in a new production facility in Waukesha, Wisconsin.

Design by Adaptive Theme
Trimed Popup
Trimed Popup